Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data, page-690

In most cases when a biotech has a share price rise like BIT has had it usually raises funds to institutional investors to its share register plus also to indicate to a partner it can go it alone and not take any low ball offer . Until i see that happening i will continue to see BIT as a HC rampathon stock.

Just look at the volume traded on ASX and CHI-X yesterday , some 94.36m shares got traded . Top 20 own around 25% and i would not consider them traders so lets assume 75% is available of the 550m listed shares or around 412m shares. Yesterdays volume represented around 23% of possible available stock.

The fact the price on both asx and chi-x closed near the low of the day and that large volume ran for the exits indicates a much lower price next week imo.